Citizen petition challenge withdrawn

Posted on December 02, 2020

On Friday, November 20, 2020, Elanco® Animal Health submitted a letter to FDA formally requesting withdrawal of their Citizen Petition. In that Citizen Petition, Elanco requested FDA to pull Monovet® 90, Huvepharma®, Inc.’s brand of monensin, from the market. Elanco, in requesting this withdrawal, has effectively agreed that Monovet® 90 has been proven safe and effective and is bioequivalent to the pioneer monensin.

“This is a great day for choice. A great day for dairy and beef producers across the U.S.,” according to Glen Wilkinson president of Huvepharma, Inc. U.S.
Click here to read the submitted letter. To view the complete line of feed additives provided by Huvepharma®, Inc. go to http://www.huvepharma.us.